Horizon Pharma to Present at the 8th Annual JMP Securities Healthcare Conference

Horizon Pharma to Present at the 8th Annual JMP Securities Healthcare Conference 
DEERFIELD, IL -- (Marketwired) -- 07/02/13 --  Horizon Pharma, Inc.
(NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman,
president and chief executive officer will present at the 8th Annual
JMP Securities Healthcare Conference on Tuesday, July 9th at 11:30
a.m. Eastern Time in New York, NY. Mr. Walbert will provide an
overview of the Company and its corporate activities. 
The presentation will be webcast live and may be accessed by visiting
Horizon's website at http://ir.horizon-pharma.com. A replay of the
webcast will be available for 10 business days.  
About Horizon Pharma
 Horizon Pharma, Inc. is a specialty
pharmaceutical company that has developed and is commercializing
DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic
needs in arthritis, pain and inflammatory diseases. The Company's
strategy is to develop, acquire, in-license and/or co-promote
additional innovative medicines where it can execute a targeted
commercial approach in specific therapeutic areas while taking
advantage of its commercial strengths and the infrastructure the
Company has put in place. For more information, please visit
www.horizonpharma.com. 
Contacts
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
investor-relations@horizonpharma.com 
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
kgalante@burnsmc.com